High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Journal: Nature Biotechnology

Published: 2020-03-30

DOI: 10.1038/s41587-020-0466-7

Affiliations: 15

Authors: 37

Go to article
Institutions Share
High Fidelity Biology (HiFiBiO), France 0.33
HiFiBiO - USA, United States of America (USA) 0.20
Laboratory of BioChemistry (LBC), CBI, France 0.15
Laboratory of Antibodies in Therapy and Pathology, France 0.14
Laboratoire de Colloïdes et Matériaux Divisés (LCMD), CBI, France 0.06
Frontières du Vivant (FDV), Université de Paris, France 0.03
Pfizer R&D Cambridge, MA, United States of America (USA) 0.03
Center of Bioinformatics, Biostatistics and Integrative Biology (C3BI), France 0.03
Structural Immunology, France 0.01
Centre of Biophysics of Macromolecules and their Interactions (PFBMI), Pasteur Institute, France 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER